SCHEMBL25190810

SCHEMBL25190810

CC(C)(C)Nc1ccc(Nc2ccc(/C=N/O)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.43
▸ GAA P10253 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ KMT2A Q03164 7/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ ACHE P22303 2/20 0.39
▸ S100B P04271 1/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ MAPT P10636 5/20 0.35
▸ SMN1; SMN2 Q16637 4/20 0.35
▸ APAF1 O14727 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ POLB P06746 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ CASP3 P42574 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26154817 0.82 MAPT (0.50) GAAKMT2AMEN1HTTMAPT
SCHEMBL5422583 0.77 S100B (0.59) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL5422579 0.77 S100B (0.59) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL25196222 0.76 CYP2A6 (0.41) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL25190699 0.75 ALDH1A1 (0.51) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL25194892 0.73 HTT (0.44) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL25194224 0.72 GRIN2D (0.48) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL4275687 0.71 KMT2A (0.64) ALDH1A1GAAKDM4EKMT2AMEN1
SCHEMBL4603900 0.71 IDO1 (0.39) ALDH1A1GAAKMT2AMEN1L3MBTL1
SCHEMBL5668373 0.71 KMT2A (0.64) ALDH1A1GAAKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
CN-115151252-A Iron death inhibitors diarylamine para-acetamides 维泰瑞隆有限公司 2022-10-04 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 ALDH1A1 395/4885GAA 4193/4885KDM4E 3495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback